Moderna says more than 40% of participants enrolled for COVID-19 vaccine trial
Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September. (Reuters photo) Drug developer Moderna Inc on Friday said it has so far enrolled 13,194 participants in the ongoing late-stage 30,000-volunteer U.S. trial testing its COVID-19 vaccine candidate. In a tweet, the company also said that 18% … Read more